Delivery Order SPE2DB20D1050-SPE2DB25FH92Q
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Mesalamine 1,000 mg suppositories in a 30-count package. This non-competitive, firm fixed-price delivery order has a ceiling value of $2,509.47 and an ultimate completion date of August 26, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $2,378.71 delivery order to AmerisourceBergen Drug Corp for Mesalamine 1,000 mg suppositories (30-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive contracting process. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine 1,000 mg suppositories (30-count units) valued at $2,493.62, with an ultimate completion date of August 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and falls under a delivery order contract type. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a $1,239.90 delivery order to AmerisourceBergen Drug Corp for 30 units of Mesalamine 1,000 mg suppositories under a firm fixed-price contract. The delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a competitively awarded, non-set-aside procurement executed through the company's existing contract vehicle with DLA. The pharmaceutical product will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,721.71 to AmerisourceBergen Drug Corp for Mesalamine 1,000 mg suppositories (30-count) on September 9, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and specifies performance at the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,133.89, is for the delivery of Mesalamine 1,000 mg suppositories. It is a Firm Fixed Price Delivery Order contract with a completion date of March 19, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award is for the delivery of Mesalamine 1,000 mg suppositories to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,968.88 and an ultimate completion date of March 28, 2025. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 27, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,044.12, is a delivery order issued by the Defense Logistics Agency (DLA) for the procurement of 4,567,342,783 units of Mesalamine 1,000 mg suppositories. The contract has an ultimate completion date of February 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mesalamine DR 1.2 GM tablets in quantities of 60 units. This is a firm fixed-price delivery order with a ceiling value of $1,556.04, with an ultimate completion date of September 4, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at twenty-five thousand six hundred eighty dollars to provide one thousand units of 1,000 mg mesalamine suppositories over a one day period from June 22 to June 23, 2023. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania in support of the Defense Logistics Agency's medical supply needs....
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH92QDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Mesalamine 1,000 mg suppositories (30-count units) with a ceiling value of $6,756.20. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and was awarded on a competitive basis without any set-aside designation. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's extensive federal contract portfolio with the Defense Logistics Agency demonstrates its established capability to fulfill diverse medical supply requirements through open competition, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 9/19/25 |